Few more weeks till the Quarterly reports, just hoping for some...

Few more weeks till the Quarterly reports, just hoping for some positive results despite this as a HYPE stock, like revenue wise and a diagnostic code CB for VA which an article was posted here by @MikesLM, or partnerships, or any god damn news aside being too dependent from the VA and Philips news.

What makes this stock look so terrible are the endless CR and on going shares issued. If that’s the case they might just want to sell this company to Philips instead. Rather than the total shares issued to reach to 1Billion then the price gets suppressed. But of course, still hoping that last Nov will be the last CR.

Aside from that, this hype stock has huge potential if managed properly especially on the sales side and get rid of unnecessary cash burning. As this company is extremely rare, first and pioneer in 4D screening. Less expectations for a hype stock unless a real revenue kicks then financial institutions will follow, to see the real potential of this company.

It’s sad to see that the volume is minimal and no news but then GLTAH. Still a cheap buy if no more CR is required or shares getting issued, NFA.